Acasti Pharma Inc. (ACST)
NASDAQ: ACST · IEX Real-Time Price · USD
2.820
+0.030 (1.08%)
At close: May 10, 2024, 3:57 PM
2.750
-0.070 (-2.48%)
After-hours: May 10, 2024, 4:00 PM EDT

Acasti Pharma Cash Flow Statement

Millions CAD. Fiscal year is Apr - Mar.
Year 202220212020201920182017201620152014
Net Income
-42.43-9.82-19.68-25.51-39.37-16.42-8.59-4.82-1.26
Depreciation & Amortization
0.1200.922.322.332.042.091.831.78
Share-Based Compensation
1.811.341.171.950.780.710.510.241.19
Other Operating Activities
24.58-8.753.26-1.7111.47-2.75-2.6-2.26-7.2
Operating Cash Flow
-15.91-17.23-14.32-22.95-24.79-16.42-8.59-5.02-5.49
Capital Expenditures
-0.020-0.07-0.32-0.53-0.35-1.93-0.21-0.03
Change in Investments
13.17-3.52-9.798.46-8.91-0.027.076.485.86
Other Investing Activities
-----0.050.110.02-0.01
Investing Cash Flow
13.15-3.52-9.868.14-9.44-0.315.266.285.82
Share Issuance / Repurchase
0.3059.6314.7345.698.715.2500.04
Debt Issued / Paid
000-1.5600000
Other Financing Activities
---0.140.01--0-0.01-0-0
Financing Cash Flow
0.3059.4913.1845.698.715.24-00.04
Exchange Rate Effect
-0.010.151.39-1-1.01-0.02-0.040.050.12
Net Cash Flow
-2.46-20.636.7-2.6310.45-1.185.151.310.48
Free Cash Flow
-15.93-17.23-14.39-23.27-25.32-16.76-10.52-5.23-5.52
Free Cash Flow Margin
---7340.82%------
Free Cash Flow Per Share
-2.14-2.81-5.82-13.21-22.39-46.02-45.49-23.55-24.96
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).